methylene blue has been researched along with Cardiomyopathies, Primary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sohn, JT | 1 |
| Lee, SS; Liu, H; Song, D | 1 |
2 other study(ies) available for methylene blue and Cardiomyopathies, Primary
| Article | Year |
|---|---|
Effect of methylene blue treatment on amlodipine toxicity-induced myocardial depression.
Topics: Amlodipine; Calcium Channel Blockers; Cardiomyopathies; Depression; Humans; Methylene Blue | 2022 |
Role of heme oxygenase-carbon monoxide pathway in pathogenesis of cirrhotic cardiomyopathy in the rat.
Topics: Animals; Blotting, Western; Carbon Monoxide; Cardiomyopathies; Cardiotonic Agents; Cyclic GMP; DNA Primers; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Guanylate Cyclase; Heat-Shock Proteins; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Isoproterenol; Liver Cirrhosis; Male; Methylene Blue; Myocardial Contraction; Papillary Muscles; Protoporphyrins; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2001 |